EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MicroRNA and renal fibrosis in autosomal dominant polycystic kidney disease: a longitudinal study

Silvia Lai iD, Daniela Mastroluca, Adolfo Marco Perrotta, Maurizio Muscaritoli, Sara Lucciola, Maria Pia Felli, Paolo Izzo, Silverio Rotondi, Sara Izzo, Lida Tartaglione, Roberta Belli, Cesarina Ramaccini und 4 weitere

Journal of Nephrology · 2024

DOI: 10.1007/s40620-024-01965-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nephrology, 2024. Verfasst von Silvia Lai und 15 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Unit, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy. silvia.lai@uniroma1.it. Hauptthemen laut MEDLINE: Polycystic Kidney, Autosomal Dominant, MicroRNAs, Kidney. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Roma La Sapienza.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Autosomal dominant polycystic kidney disease (ADPKD) is a hereditary kidney disorder that may progress to kidney failure, accounting for 5–10% of all patients with end-stage kidney disease (ESKD). Clinical data, as well as molecular genetics and advanced imaging techniques have provided surrogate prognostic biomarkers to predict rapid decline in kidney function, nonetheless enhanced tools for assessing prognosis for ADPKD are still needed. The aim of this study was to analyze specific microRNAs involved in the pathogenesis of ADPKD and in the development of renal fibrosis, evaluating their potential role as predictors of renal function loss.

Methods

We evaluated kidney function by estimated glomerular filtration rate (eGFR) in 32 ADPKD patients in different stages of kidney disease at T0 and after a 24-month follow up (T1). Patients were divided into two groups: Rapid disease progression ([RP], n 15) and Non-rapid disease progression ([NRP], n 17), according to the Mayo Clinic classification criteria. At T0, ADPKD patients underwent plasma sampling for quantitative analysis of h-miR-17-5p, h-miR-21-5p and h-miR-199a-5p microRNA expression, using the quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) method and a 3 T magnetic resonance imaging (MRI), using an advanced MRI imaging protocol, for the quantification of total kidney volume (TKV), total perfusion volume (TPV) and total fibrotic volume (TFV).

Results

The expression of h-miR17-5p was higher ( p < 0.05) in ADPKD patients with rapid disease progression. h-miR-17-5p, h-miR-21-5p and h-mir-199-5p showed a positive and significant correlation with the eGFR slope (mL/min/1.73 m 2 /year) ( p < 0.05) but not with the eGFR at both T0 and T1. Both total fibrotic volume (cm 3 ) and height-adjusted total fibrotic volume (cm 3 /m) were positively and significantly correlated to h-miR 21-5p and h-miR 199-5p ( p < 0.05), but not to total kidney volume (cm 3 ) and height-adjusted total kidney volume (cm 3 /m).

Conclusions

The microRNAs we studied were associated with fibrosis and renal damage, suggesting their possible role as biomarkers able to identify ADPKD patients at high risk of disease progression regardless of the degree of kidney function, and therefore suitable for medical therapy, and may help uncovering new molecular mechanisms underlying cystogenesis. Graphical abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Kidney, Autosomal DominantMicroRNAsKidneyHumansMaleFemaleFibrosisMiddle AgedDisease ProgressionGlomerular Filtration RateAdultLongitudinal StudiesBiomarkers

Stichwörter der Autor:innen

Autosomal dominant polycystic kidney diseasePlasma aldosteroneSubclinical atherosclerosis parametersTotal fibrotic volume

Substanzen

MicroRNAsMIRN17 microRNA, humanMIRN21 microRNA, humanmirn199 microRNA, humanBiomarkers

Autor:innen und Institutionen

  • Nephrology Unit, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy. silvia.lai@uniroma1.it.
  • Nephrology Unit, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
  • Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
  • Department of Radiological Sciences, Oncology and Pathology, Sapienza University of Rome, Rome, Italy.
  • Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
  • Pietro Valdoni, Department of Surgery, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.

ORCID-Profile: Silvia Lai

Förderung

  • Università degli Studi di Roma La Sapienza

Zitieren

APA

Lai, S., Mastroluca, D., Perrotta, A. M., Muscaritoli, M., Lucciola, S., Felli, M. P., Izzo, P., Rotondi, S., Izzo, S., Tartaglione, L., Belli, R., Ramaccini, C., Izzo, L., De Intinis, C., Panebianco, V., & Mazzaferro, S. (2024). MicroRNA and renal fibrosis in autosomal dominant polycystic kidney disease: a longitudinal study. Journal of Nephrology. https://doi.org/10.1007/s40620-024-01965-0

Vancouver

Lai S, Mastroluca D, Perrotta AM, Muscaritoli M, Lucciola S, Felli MP, et al. MicroRNA and renal fibrosis in autosomal dominant polycystic kidney disease: a longitudinal study. Journal of Nephrology. 2024. doi:10.1007/s40620-024-01965-0

BibTeX
@article{Lai2024,
  author = {Lai, Silvia and Mastroluca, Daniela and Perrotta, Adolfo Marco and Muscaritoli, Maurizio and Lucciola, Sara and Felli, Maria Pia and Izzo, Paolo and Rotondi, Silverio and Izzo, Sara and Tartaglione, Lida and Belli, Roberta and Ramaccini, Cesarina and Izzo, Luciano and De Intinis, Claudia and Panebianco, Valeria and Mazzaferro, Sandro},
  title = {MicroRNA and renal fibrosis in autosomal dominant polycystic kidney disease: a longitudinal study},
  journal = {Journal of Nephrology},
  year = {2024},
  doi = {10.1007/s40620-024-01965-0}
}
Kostenlos starten →